Cargando…

Three-dimensional heart extracellular matrix enhances chemically induced direct cardiac reprogramming

Direct cardiac reprogramming has emerged as a promising therapeutic approach for cardiac regeneration. Full chemical reprogramming with small molecules to generate cardiomyocytes may be more amenable than genetic reprogramming for clinical applications as it avoids safety concerns associated with ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Yoonhee, Kim, Hyeok, Min, Sungjin, Choi, Yi Sun, Seo, Seung Ju, Jeong, Eunseon, Kim, Su Kyeom, Lee, Hyang-Ae, Jo, Sung-Hyun, Park, Jae-Hyun, Park, Bong-Woo, Sim, Woo-Sup, Kim, Jin-Ju, Ban, Kiwon, Kim, Yun-Gon, Park, Hun-Jun, Cho, Seung-Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750148/
https://www.ncbi.nlm.nih.gov/pubmed/36516259
http://dx.doi.org/10.1126/sciadv.abn5768
Descripción
Sumario:Direct cardiac reprogramming has emerged as a promising therapeutic approach for cardiac regeneration. Full chemical reprogramming with small molecules to generate cardiomyocytes may be more amenable than genetic reprogramming for clinical applications as it avoids safety concerns associated with genetic manipulations. However, challenges remain regarding low conversion efficiency and incomplete cardiomyocyte maturation. Furthermore, the therapeutic potential of chemically induced cardiomyocytes (CiCMs) has not been investigated. Here, we report that a three-dimensional microenvironment reconstituted with decellularized heart extracellular matrix can enhance chemical reprogramming and cardiac maturation of fibroblasts to cardiomyocytes. The resultant CiCMs exhibit elevated cardiac marker expression, sarcomeric organization, and improved electrophysiological features and drug responses. We investigated the therapeutic potential of CiCMs reprogrammed in three-dimensional heart extracellular matrix in a rat model of myocardial infarction. Our platform can facilitate the use of CiCMs for regenerative medicine, disease modeling, and drug screening.